Central nervous system efficacy of rezivertinib (BPI-7711) in advanced NSCLC patients with EGFR T790M mutation: A pooled analysis of two clinical studies.
暂无分享，去创建一个
T. Wang | D. Zhong | Yanqiu Zhao | Y. Shu | Yu-Mei Shi | Zhe-feng Liu | C. Xie | Gong-yan Chen | Guofang Zhao | Yun Fan | Longzhen Zhang | Sheng-hua Sun | Zhongliang Guo | Donglin Wang | Lijun Wang | R. Zheng | S. Cang | Bo Zhu | Zhendong Chen | Chunling Liu | Z. Zhuang | Z. Meng | Yueyin Pan | Meili Sun | Anqi Zhou | Shengxiang Hu | Jianhua Shi | Xingya Li | W. Yao | Huiqing Yu | Wen Li | R. Ma | Liang-ming Zhang | Gang Wu | Shanyong Yi | T. Yi | Zhi-Xiong Yang | Yanzhen Guo | Yingcheng Lin | M. Bi | Zhigang Han | Kenneth K. Wang | M. Greco | Jing-zhang Li | Jiwei Liu | Shuliang Guo | J. Fang | Jianan Huang | Meijuan Huang | Zhaohong Chen | Zheng Liu | Jianying Zhou | Huimin Zhao | Shiman Wu | Sheng Yang | Lin-chang Wu | Hongli Lu | Gongyan Chen